Bellerophon Therapeutics Market Cap

Bellerophon Therapeutics has a market cap or net worth of $146.79 thousand as of December 27, 2024. Its market cap has decreased by -96.89% in one year.

Market Cap

146.79K

Enterprise Value

-4.24M

Revenue

5.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.01

Market Cap Chart

Since February 13, 2015, Bellerophon Therapeutics's market cap has decreased from 115.76M to 146.79K, a decrease of -99.87%. That is a compound annual growth rate of -49.19%.

Market Cap History

Date	Market Cap	% Change
Dec 18, 2024	146.79K	-67.57%
Dec 29, 2023	452.61K	-94.73%
Dec 30, 2022	8.59M	-70.85%
Dec 31, 2021	29.47M	-53.48%
Dec 31, 2020	63.35M	163.68%
Dec 31, 2019	24.03M	-48.91%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.18B
Telix Pharmaceuticals Limited	5.29B
Elekta AB (publ)	2.19B
Ryman Healthcare Limited	1.70B
Verano Holdings Corp.	468.46M
Vireo Growth Inc.	57.89M
Medexus Pharmaceuticals Inc.	50.57M

Market Cap Rankings